CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2016	Jan. 31, 2015	Apr. 30, 2016	Apr. 30, 2015
Operating Expenses:
Research and development	$ 71,028	$ 224,026	$ 316,226	$ 854,706
General and administrative (Note 4)	73,270	627,575	1,303,182	1,740,511
Total Operating Expenses	144,298	851,601	1,619,408	2,595,217
Operating Loss	(144,298)	(851,601)	(1,619,408)	(2,595,217)
Other Income/(Expense):
Interest income				11
Interest expense	(106,855)	(89,372)	(306,765)	(256,574)
Change in fair value of derivative liabilities (Note 8)	1,169,514	(455,184)	1,065,880	665,491
Gain on extinguishment of debt (Note 4)				327,839
Net (loss) / Income	$ 918,361	$ (1,396,157)	$ (860,293)	$ (1,858,450)
Net (Loss) Income per Common Share (Note 6) - Basic	$ 0.001	$ (0.002)	$ (0.001)	$ (0.002)
Net (Loss) Income per Common Share - Diluted	$ 0.001	$ (0.002)	$ (0.001)	$ (0.002)
Basic Shares Used to Compute (Loss) / Income per Share (Note 6)	900,056,574	791,855,062	873,308,920	787,175,380
Diluted Shares Used to Compute (Loss) / Income per Share (Note 6)	900,132,870	816,797,835	873,308,920	787,175,380
Other Comprehensive (Loss) / Income
Net (loss) / Income	$ 918,361	$ (1,396,157)	$ (860,293)	$ (1,858,450)
Change in foreign currency translation adjustments	(15,695)	(9,553)	(20,782)	21,682
Comprehensive (Loss) / Income	$ 902,666	$ (1,405,710)	$ (881,075)	$ (1,836,768)